All In Biotech

Drug Trial Radar · NCT05911217

A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

An Open-label, Single-arm, Multicenter, Phase Ib Clinical Trial to Evaluate the Efficacy and Safety of CT041 Autologous CAR T Cell Injection After Adjuvant Chemotherapy in Subjects With Pancreatic Cancer

Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jul 11, 2023

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
CARsgen Therapeutics Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Fudan University
First posted
Jun 20, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open-label, single-arm, multicenter, Phase Ib clinical trial to evaluate the efficacy and safety of CT041 Autologous CAR T Cell Injection after adjuvant chemotherapy in subjects with pancreatic cancer.

Conditions

  • Pancreatic Cancer

Interventions

  • CT041 autologous CAR T-cell injectionDrug

    Treatment with anti-claudin18.2 chimeric antigen receptor T-cell infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease free survival (DFS)Time frame: Up to 18 months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Recruiting

  • Union Hospital, Tongji Medical College, Hua zhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • Hunan Provincial People's Hospital

    Changsha, Hunan, China · Recruiting

  • Ruijin Hospital, affiliated to Shanghai Jiaotong University, school of medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Fudan University Shanghai Cancer Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xian, Shanxi, China · Recruiting

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.